Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (319)
ARTG (296)
Prescription medicine registration (28)
Designation or determination (2)
Prescription medicine evaluation (2)

Date

2026 (39)
2025 (30)
2024 (51)
2023 (161)
2022 (30)
2021 (55)
2020 (48)
2019 (26)
2018 (53)
2017 (35)
2016 (77)
2015 (2)
2014 (2)
2013 (9)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

647 result(s) found, displaying 71 to 80

REDDY'S-ERIBULIN eribulin mesilate 1 mg/2 mL solution for injection vial (390345)

22 October 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REDDY'S-ERIBULIN eribulin mesilate 1 mg/2 mL solution for injection vial.
ERIBULIN-RZ eribulin mesilate 1 mg/2 ml solution for injection vial (390343)

22 October 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ERIBULIN-RZ eribulin mesilate 1 mg/2 ml solution for injection vial.
ERIBULIN-DRLA eribulin mesilate 1 mg/2 mL solution for injection vial (390344)

22 October 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ERIBULIN-DRLA eribulin mesilate 1 mg/2 mL solution for injection vial.
APIXABAN DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

28 April 2025

Prescription medicine registration

Active ingredients: apixaban.
LINAGLIPTIN DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

21 March 2025

Prescription medicine registration

Active ingredients: linagliptin.
PAZOPANIB DR. (Dr Reddys Laboratories Australia Pty Ltd)

19 March 2025

Prescription medicine registration

Active ingredients: pazopanib hydrochloride.
ISOTRETINOIN DR REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

7 March 2025

Prescription medicine registration

Active ingredients: isotretinoin.
ABIRATERONE DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

18 February 2025

Prescription medicine registration

Active ingredients: abiraterone acetate.
MIDOSTAURIN (Dr Reddys Laboratories Australia Pty Ltd)

4 February 2025

Prescription medicine registration

Active ingredients: midostaurin.
AZACITIDINE JUNO azacitidine 100 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

11 December 2024

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
…
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Page 11
Page 12
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.